Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nuclear reprogramming: a key to stem cell function in regenerative medicine.

Jason Pomerantz1, Helen M Blau

  • 1Baxter Laboratory in Genetic Pharmacology and Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.

Nature Cell Biology
|September 2, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

15-PGDH inhibition promotes muscle repair and strength recovery during GLP-1 receptor agonist-induced weight loss.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

15-PGDH Inhibition Overcomes Muscle Regenerative Deficit Seen With GLP1-Receptor Agonist-Induced Weight Loss.

bioRxiv : the preprint server for biology·2026
Same author

Telomere shortening in laminopathic dilated cardiomyopathy.

NPJ Regenerative medicine·2026
Same author

Integrative transcriptomic profiling links telomere dysfunction to cGAS-STING activation in heart failure signatures in mice and humans.

Cardiovascular research·2026
Same author

Inhibition of 15-hydroxy prostaglandin dehydrogenase promotes cartilage regeneration.

Science (New York, N.Y.)·2025
Same author

From Cell Reprogramming to Tissue Rejuvenation: Countering Aging by Targeting a Gerozyme.

Annual review of pharmacology and toxicology·2025
Same journal

Author Correction: Mitochondrial fission links ECM mechanotransduction to metabolic redox homeostasis and metastatic chemotherapy resistance.

Nature cell biology·2026
Same journal

An atlas of primate insular cortex reveals a signal-processing strategy in von Economo neurons.

Nature cell biology·2026
Same journal

Primate neurons with special signalling logic.

Nature cell biology·2026
Same journal

Cell surface liposome binding (CLiB) allows lipid-binding probe engineering via high-throughput screening.

Nature cell biology·2026
Same journal

Mapping the human female reproductive tract.

Nature cell biology·2026
Same journal

Learning from stem cell-based embryo models.

Nature cell biology·2026
See all related articles

Bone marrow-derived cells (BMDCs) show potential in regenerative medicine by incorporating into damaged tissues and reprogramming. This cellular plasticity offers promise for developing new therapies for various tissue types.

Area of Science:

  • Regenerative Medicine
  • Cellular Biology
  • Tissue Engineering

Background:

  • Regenerative medicine aims to restore tissue form and function.
  • Autologous bone marrow-derived cells (BMDCs) are a potential therapeutic tool.
  • Evidence suggests nuclear plasticity and cell reprogramming capabilities.

Purpose of the Study:

  • To explore the potential of bone marrow-derived cells (BMDCs) in regenerative medicine.
  • To investigate the capacity of endogenous BMDCs to repair damaged tissues.
  • To assess the promise of BMDCs for cellular therapies.

Main Methods:

  • Review of advances in nuclear transplantation and heterokaryon formation.
  • Analysis of studies reporting gene expression and phenotype plasticity.

Related Experiment Videos

  • Examination of recent observations on endogenous BMDC incorporation and reprogramming.

    • Main Results:

    • Bone marrow-derived cells (BMDCs) demonstrate plasticity in gene expression and phenotype.
    • Endogenous BMDCs can incorporate into defective tissues.
    • BMDCs exhibit reprogramming capacity within recipient tissues.

    Conclusions:

    • BMDCs hold significant promise for regenerative medicine applications.
    • The reprogramming potential of BMDCs can be harnessed for therapeutic purposes.
    • BMDCs offer a viable strategy for treating both proliferative and post-mitotic tissues.